作者: Sarah A. Martin , Nuala McCabe , Michelle Mullarkey , Robert Cummins , Darren J. Burgess
DOI: 10.1016/J.CCR.2009.12.046
关键词:
摘要: Synthetic sickness/lethality (SSL) can be exploited to develop therapeutic strategies for cancer. Deficiencies in the tumor suppressor proteins MLH1 and MSH2 have been implicated Here we demonstrate that deficiency is SSL with inhibition of DNA polymerase POLB, whereas POLG inhibition. Both SSLs led accumulation 8-oxoG oxidative lesions. MSH2/POLB caused nuclear accumulation, MLH1/POLG a rise mitochondrial levels. were rescued by silencing adenine glycosylase MUTYH, suggesting lethality could formation lethal breaks upon accumulation. These data suggest targeted, mechanism-based approaches.